Lung Cancer
Conference Coverage
Therapeutic vaccine shows promise in treating lung cancer
“We realized that just half of patients really benefited from the vaccine: those who had previously responded to immunotherapy.”
Opinion
New ‘C word’: Cure should be the goal for patients with lung cancer
I didn’t hear it at ASCO, but the truth of the matter is that’s a word we should be using and be using more.
Feature
Many patients with NSCLC receive immunotherapy ‘indefinitely’ – Are they benefiting?
Without “incontrovertible evidence” that immunotherapy should stop at 2 years, “many, many, many patients and clinicians are going to favor...
Latest News
Adaptive treatment aids smoking cessation
Patches for smoking cessation were more successful with added bupropion for nonresponders.
Networks
Mepolizumab improves asthma after 1 year despite comorbidities
Patients with asthma and comorbid chronic rhinosinusitis with nasal polyps showed especially significant benefits.
From the Journals
Diabetes may short circuit pembrolizumab benefits in NSCLC
"There is an urgent need to validate our findings and explore whether outcomes in these patients can be improved by better glycemic control."
Conference Coverage
Multiprong strategy makes clinical trials less White
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
Latest News
T-DXd active in many solid tumors; ‘shift in thinking’
T-DXd is a potential new treatment option for patients with HER2-expressing solid tumors, experts say.
Feature
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...